RE:RE:At last a schedule Thanks for your reply.
The million dollar question is whether they can treat GBM - and maybe even NSCLC - with Rutherrin and X-ray only? Roswell Park are limited to TLD-1433 which cannot be activated exogenously so they have to use their OSA plus Digilum. If TLT can make these compounds work non-invasively then things should hot up very quickly next year. A substantial partial response was observed preclinically with X-Ray at levels 27-fold less the those used in historic attempts to destroy GBM so there is probably good leeway to increase the light dose from there.
Yes G1 timelines have slipped time and again but they have been experimenting with Rutherrin for over 5 years now. It is a known quantity to them in terms of toxicity which represents the greatest majority of the remaining preclinical work.